Yahoo
HKSE - Delayed Quote HKD

LifeTech Scientific Corporation (1302.HK)

1.660 +0.120 (+7.79%)
At close: 4:08:08 PM GMT+8
Chart Range Bar
Loading chart for 1302.HK
  • Previous Close 1.540
  • Open 1.540
  • Bid 1.655 x --
  • Ask 1.660 x --
  • Day's Range 1.535 - 1.670
  • 52 Week Range 1.255 - 2.380
  • Volume 51,296,000
  • Avg. Volume 19,397,784
  • Market Cap (intraday) 7.305B
  • Beta (5Y Monthly) 0.40
  • PE Ratio (TTM) 166.00
  • EPS (TTM) 0.010
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. It is also involved in biomedical research and development; properties leasing business; and developing, manufacturing, and trading of medical devices, as well as offers technical, consulting, and technology services. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, China.

www.lifetechmed.com

1,254

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/4/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

1302.HK
6.41%
HANG SENG INDEX (^HSI)
6.68%

1-Year Return

1302.HK
15.74%
HANG SENG INDEX (^HSI)
7.83%

3-Year Return

1302.HK
28.76%
HANG SENG INDEX (^HSI)
35.41%

5-Year Return

1302.HK
53.50%
HANG SENG INDEX (^HSI)
5.18%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.51%

  • Return on Assets (ttm)

    2.32%

  • Return on Equity (ttm)

    0.64%

  • Revenue (ttm)

    1.29B

  • Net Income Avi to Common (ttm)

    58.41M

  • Diluted EPS (ttm)

    0.010

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.24B

  • Total Debt/Equity (mrq)

    0.43%

  • Levered Free Cash Flow (ttm)

    508.32M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: